VVUS

VIVUS, Inc. News Headlines

$2.42
*  
unch
unch
Get VVUS Alerts
*Delayed - data as of Apr. 17, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







Orexigen: Contrave Scripts Pass 9,000 - Closing In On Qsymia
2/23/2015 11:00:00 AM - Seeking Alpha




Arena's Belviq Slows At A Bad Time
2/23/2015 9:57:00 AM - Seeking Alpha










Orexigen's Contrave Resumes Solid Growth Rate
2/17/2015 8:45:00 AM - Seeking Alpha


Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
2/8/2015 12:14:00 AM - Seeking Alpha


Vivus' Qsymia Headed In The Wrong Direction
2/7/2015 5:44:00 AM - Seeking Alpha


Orexigen: Contrave Script Sales Dip. Why?
2/6/2015 6:36:00 PM - Seeking Alpha


Arena Scripts Grow, But Pace Is Slower Than Needed
2/6/2015 6:31:00 PM - Seeking Alpha


Arena's Belviq Keeps Up Momentum During A Flat Week
2/6/2015 4:05:00 PM - Seeking Alpha






Arena Pharmaceuticals' Belviq Set To Surge In 2015
2/2/2015 1:47:00 PM - Seeking Alpha




Arena's Belviq Conquers MLK Week According To Symphony
2/2/2015 8:38:00 AM - Seeking Alpha




Contrave Scripts Continue Increases For Orexigen
1/27/2015 3:33:00 PM - Seeking Alpha